Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Multi

CP Invest Fond Farmacie a Biotechnologie

+ Add to Watchlist

FFBCPIN:CP

1.86 CZK

As of 00:00:00 ET on 05/20/2015.

Snapshot for CP Invest Fond Farmacie a Biotechnologie (FFBCPIN)

Year To Date: +10.59% 3-Month: +3.77% 3-Year: +25.84% 52-Week Range: 1.48 - 1.88
1-Month: +0.48% 1-Year: +27.70% 5-Year: +18.96% Beta vs PX: 0.55

Mutual Fund Chart for FFBCPIN

No chart data available.
  • FFBCPIN:CP 1.86
  • 1M
  • 1Y
Interactive FFBCPIN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FFBCPIN

CP Invest Fond Farmacie a Biotechnologie is an open-end fund incorporated in Czech Republic. The Funds objective is long-term capital growth. The fund invests primarily in equity securities issued by larger pharmaceutical and biotechnology companies located in the United States and Europe.

Inception Date: 01-09-2002 Telephone: -
Managers: -
Web Site: -

Fundamentals for FFBCPIN

NAV (on 2015-05-20) 1.86
Assets (M) (on 2015-05-20) 997.68
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for FFBCPIN

No dividends reported

Fees & Expenses for FFBCPIN

Front Load -
Back Load -
Current Mgmt Fee -
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for FFBCPIN

Filing Date: 04/30/2015
Name Position Value % of Total
Pfizer Inc 52,230 42,992,947 4.570%
Amgen Inc 10,304 39,606,194 4.210%
Gilead Sciences Inc 15,574 38,289,124 4.070%
Sanofi 12,963 31,421,541 3.340%
Actavis plc 4,514 31,233,388 3.320%
Johnson & Johnson 11,205 27,188,100 2.890%
Biogen Inc 2,880 26,341,412 2.800%
AstraZeneca PLC 15,051 25,212,494 2.680%
iShares Nasdaq Biotechnology E 2,974 24,271,729 2.580%
Abbott Laboratories 21,044 23,895,424 2.540%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil